Table 2

Parameter changes of cardiac status and renal function, plasma lyso-Gb3 and Mainz Severity Score Index (MSSI) at baseline and after 6–39 months of enzyme replacement therapy (ERT) for 36 Taiwanese patients with Fabry disease

Plasma
lyso-Gb3 (nM)*
eGFR (mL/min/1.73 m2) (CKD-EPI)Urine ACR (mg/mmol)LVM (g)LVMI (g/m2.7)IVS (mm)LPW (mm)MSSI (max score=76)Adverse effects
No.TypeAge at ERT (year)GenderERT duration (months)BaselineAfter ERTBaselineAfter ERTBaselineAfter ERTBaselineAfter ERTBaselineAfter ERTBaselineAfter ERTBaselineAfter ERTBaselineAfter ERT
1Cardiac25M144.11.873.3101.10.460.49221.3NA48.8NA8.7NA10NA99N
2Cardiac43M394.443.36109.6115.10.350.48392.127092.163.416.713.71212.22117N
3Cardiac53M395.194.1899.792.50.850.30298.51987650.414.612.815.211.72420N
4Cardiac54M106.134.7193.993.31.700.28303.030474.574.814.71214.7121616N
5Cardiac55M178.22872.280.113.310.66272.1342.866.583.815.21412.8122727N
6Cardiac55M195.443.6771.369.92.430.27188.814850.539.612.712.57.39.52424N
7Cardiac57M136.77NA94.997.83.943.28148.2138.743.841.015.49.96.472021N
8Cardiac59M1213.519.8667.963.20.300.43185.3244.351.267.513.313.3910.72525N
9Cardiac60M125.064.3886.7961.970.49204.113050.632.210.599.39.51614N
10Cardiac62M1511.523.7992.595.90.811.07276.9403.975.9110.718.61210.1102020N
11Cardiac63M1814.548.1994.8901.070.25340.8302.188.278.21215.31413.31717N
12Cardiac63M353.494.1793.489.75.650.47383.633688.777.719.717.712.68.22521N
13Cardiac64M69.778.6666.882.80.670.51544.8439136.4109.93022.328.616.63131N
14Cardiac65M88.084.4976.183.50.253.67179.1NA55.2NA16NA8NA2222N
15Cardiac67M327.810.8100.998.41.070.15195.619152.351.115.420.2810.72324Y
16Classic14M27178.475.64133.8141.20.990.74225.2NA57.3NA10.19.911.79.91717Y
17Classic23M9203.6874.51108119.71.140.68323.324257.142.81211.311.310.71917N
18Classic33M1654.9545.1385.783.1171.68NA282.2181.968.544.2139.51110.62725Y
19Classic49M1671.4858.831.525.3111.8411.53151.6227.130.545.710.513.377.33234Y
20Cardiac44F82.231.34106.7112.70.770.89204.610457.529.21159.581715N
21Cardiac53F152.591.29103.6NA0.660.74143.0NA45.4NA9NA6.4NA1515N
22Cardiac58F242.601.202612.1286.24117.22186.511459.236.212.59.9138.82519Y
23Cardiac59F173.493.1177.294.313.114.09169.0133.853.442.313.31186.52115N
24Cardiac63F94.241.4796.296.66.140.67179.094.452.127.511.57.611.57.61711N
25Cardiac67F123.67NA91.199.10.760.33194.7193.86463.71212.712.711.81818N
26Classic33F1611.747.08114.7117.40.730.52124.5131.735.637.79.189.1654Y
27Classic34F2524.812.57107.9120.2355.33105.94122.2155.738.148.578.68.29.51820Y
28Classic48F178.976.85108.21062.033.43168.7155.755.951.615.79.38.88.82929Y
29Classic53F64.664.5697.2100.140.0855.31195.615862.650.6129.51010.82121N
30Classic54F2617.2611.70105.6104.24.101.81216.818272.560.91510.11410.82715N
31Classic56F1211.4112.1610984.10.691.86211.823351.156.29.316.39.911.52226Y
32Classic58F1620.1217.1777.182.33.792.81123.9101.258.735.110.59.58.682523Y
33Classic58F2031.7721.0086.778.15.530.31255.7250.482.680.816.414.311.111.33838Y
34Classic66F1118.3814.037774.313.572.03468.3431.1146.5134.824.522.516.314.43535N
35Classic76F828.1223.3254.760.94.190.58352.4272120.192.71818.31814.53434Y
36Classic79F1211.5510.3672.573.236.341.41NANANANA21169113434N
Mean
SD
53.4
14.4
17
8.8
24.1
44.9
14.2
19.6
87.9
22
89.5
24.6
30.4
79.4
9.3
27.2
247.2
102.9
219.7
97.1
68.2
26.9
60
26.1
14.3
4.6
12.6
4.2
11.5
4.1
10.3
2.4
22.7
7.1
21.5
7.7
       p value†0.043NSNS0.0150.0080.0060.0240.019 
       N3435353131333336 
  • *Reference range: <0.01–0.5.

  • †Paired t test, significance at p<0.05.

  • ACR, albumin-to-creatine ratio; eGFR, estimated glomerular filtration rate; IVS, intraventricular septum; LPW, left posterior wall; LVM, left ventricular mass; LVMI, left-ventricular mass index; lyso-Gb3, globotriaosylsphingosine; NA, not available; NS, not significant.